Bitemporal Hemianopia
- Boot Camp

- Oct 15, 2023
- 0 min read
History Taking
Chief Complaint:
Complaints of visual loss, usually peripheral vision
Difficulty in reading, driving, or navigating spaces
Bumping into objects
History of Presenting Complaint:
Noticing gaps or blind spots in the field of vision
Gradual, insidious onset
May have associated headaches
Often, visual disturbances are more pronounced in low light conditions
System Review:
Headache, particularly if persistent or worsening
Symptoms suggestive of pituitary dysfunction such as weight gain, lethargy, menstrual irregularities (due to pituitary adenoma)
Acromegalic features such as enlarged hands, feet, facial changes (due to growth hormone-secreting pituitary adenoma)
Symptoms of hyperthyroidism such as weight loss, palpitations, heat intolerance (due to TSH-secreting pituitary adenoma)
Symptoms of adrenal insufficiency like fatigue, weight loss, hypotension, salt craving (secondary to ACTH deficiency)
Galactorrhea, decreased libido, infertility (due to prolactin-secreting pituitary adenoma)
Past Medical History:
History of other visual disturbances or eye disease
History of endocrine disorders
History of neurological disorders or neurosurgical interventions
History of cranial radiation therapy
Past Surgical History:
History of brain or pituitary surgery
History of any radiation treatment
Drug History:
Use of medications such as corticosteroids which can affect the pituitary gland
Medications for existing endocrine disorders
Family History:
Family history of pituitary tumors or other endocrine disorders
Family history of visual disturbances or eye diseases
Personal History:
Any history of trauma or injury to the head or eyes
Exposure to radiation or toxic substances
Social History:
Impact of visual symptoms on daily activities, work, or driving
Support system available, especially if visual loss is significant
Physical Examination
General Examination:
Observe for acromegalic features (large hands and feet, coarse facial features, prominent jaw) indicative of a growth hormone-secreting pituitary adenoma
Look for signs of Cushing's syndrome such as central obesity, 'moon face', and 'buffalo hump', indicative of ACTH-secreting pituitary adenoma
Notice any signs of hypogonadism such as reduced body hair or gynecomastia in males, amenorrhea in females (due to pituitary adenoma)
Face (Eyes, Nose, Mouth):
Bitemporal hemianopia observed during visual field testing
Optic atrophy or papilledema on fundoscopy
Neurological Examination:
Assessment of visual acuity might show reduction
Assessment of visual fields will show loss of vision in the outer (temporal) half of both eyes
Cranial nerve examination is important, specifically cranial nerve II (optic nerve) for visual acuity, visual fields, color vision, and fundoscopy; and cranial nerve III (oculomotor nerve) for pupillary reactions and eye movements
Other cranial nerves may be affected, especially in larger lesions or with mass effect, so a full cranial nerve examination should be undertaken
Additional Examination if Required:
Endocrine assessment may be necessary if symptoms suggestive of hormonal hyper- or hyposecretion are present. This could include tests of thyroid, adrenal, and gonadal function
Investigations
Laboratory Tests:
Complete blood count: Can show anemia or other hematological abnormalities associated with some pituitary disorders
Serum prolactin: Elevated in prolactinomas
Serum growth hormone and insulin-like growth factor-1: Elevated in acromegaly
Serum TSH and free thyroxine: Assess thyroid function, could be abnormal in a TSH-secreting pituitary adenoma
Serum ACTH and cortisol: Assess adrenal function, could be abnormal in a ACTH-secreting pituitary adenoma
Serum FSH, LH, testosterone/estradiol: Assess gonadal function, could be abnormal in gonadotroph-secreting pituitary adenoma
Imaging Studies:
Magnetic Resonance Imaging (MRI) of the brain with contrast: Gold standard for visualizing pituitary tumors or other structural lesions causing the bitemporal hemianopia
Computed Tomography (CT) scan of the brain: If MRI is contraindicated or not available, a CT can provide some information, though it is less sensitive than MRI for detecting pituitary tumors
Invasive Tests:
Visual field testing (perimetry): Though technically non-invasive, this is a specific test to map the visual field loss in detail
Lumbar puncture: If there is concern about intracranial hypertension as a cause of papilledema
Other Tests:
Dynamic pituitary function tests: These can include tests like the dexamethasone suppression test or growth hormone suppression test, depending on the suspected pituitary disorder
Management
General Management:
Patient education about the nature of the disease and treatment options
Regular follow-ups for monitoring disease progression and treatment response
Medical Management:
Dopamine agonists like cabergoline or bromocriptine for prolactin-secreting adenomas
Somatostatin analogs (like octreotide) or growth hormone receptor antagonists (like pegvisomant) for growth hormone-secreting adenomas
Steroid replacement for ACTH deficiency, levothyroxine for TSH deficiency, sex hormone replacement for gonadotropin deficiency
For hormone secreting adenomas, medications to block the effects of excess hormones may be used (such as antithyroid drugs for a TSH-secreting adenoma)
Surgical Management:
Transsphenoidal surgery to remove the pituitary tumor is often the first-line treatment for larger or symptomatic tumors, especially if causing significant visual impairment
Craniotomy may be required for larger tumors or if transsphenoidal approach is not feasible
Radiotherapy (either conventional or stereotactic) may be used as adjunctive therapy after surgery, especially in tumors not completely removed or for non-resectable tumors
Other Management:
For visual symptoms, referral to an ophthalmologist for further management and regular visual field testing to monitor disease progression
For pituitary apoplexy (a rare but serious complication), urgent neurosurgical referral is required
Regular endocrinology follow-up for patients with residual pituitary function or requiring ongoing medical treatment for pituitary tumors
Psychosocial support and counselling as needed, given the chronic nature of the disease and potential impact on quality of life
Consideration of genetic counselling and screening for familial conditions in patients with certain types of pituitary tumors.
